@ARTICLE{
author={Robinson Michael F|,Damjanov Nemanja S|,Stamenkovic Bojana N|0000-0003-3581-4867,Radunovic Goran L|0000-0002-4449-8969,Kivitz Alan J|,Cox Lori|,Manukyan Zorayr|,Banfield Christopher|,Saunders Michael|,Chandra Deepa|,Vincent Michael S|,Mancuso Jessica|,Peeva Elena|,Beebe Jean S|},
year={2020},
title={Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={10},
pages={1621-1631},
document_type={Article},
} 

@ARTICLE{
author={Robinson Michael F|,Damjanov Nemanja S|,Stamenkovic Bojana N|0000-0003-3581-4867,Radunovic Goran L|0000-0002-4449-8969,Kivitz Alan J|,Cox Lori|,Manukyan Zorayr|,Banfield Christopher|,Saunders Michael|,Chandra Deepa|,Vincent Michael S|,Mancuso Jessica|,Peeva Elena|,Beebe Jean S|},
year={2020},
title={Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={10},
pages={1621-1631},
document_type={Article},
}